1. Home
  2. KTF vs ALT Comparison

KTF vs ALT Comparison

Compare KTF & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KTF
  • ALT
  • Stock Information
  • Founded
  • KTF 1988
  • ALT 1997
  • Country
  • KTF United States
  • ALT United States
  • Employees
  • KTF N/A
  • ALT N/A
  • Industry
  • KTF Finance Companies
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • KTF Finance
  • ALT Health Care
  • Exchange
  • KTF Nasdaq
  • ALT Nasdaq
  • Market Cap
  • KTF 337.7M
  • ALT 292.0M
  • IPO Year
  • KTF N/A
  • ALT N/A
  • Fundamental
  • Price
  • KTF $8.79
  • ALT $3.83
  • Analyst Decision
  • KTF
  • ALT Strong Buy
  • Analyst Count
  • KTF 0
  • ALT 6
  • Target Price
  • KTF N/A
  • ALT $17.40
  • AVG Volume (30 Days)
  • KTF 103.3K
  • ALT 3.0M
  • Earning Date
  • KTF 01-01-0001
  • ALT 08-12-2025
  • Dividend Yield
  • KTF 3.54%
  • ALT N/A
  • EPS Growth
  • KTF N/A
  • ALT N/A
  • EPS
  • KTF 0.39
  • ALT N/A
  • Revenue
  • KTF N/A
  • ALT $20,000.00
  • Revenue This Year
  • KTF N/A
  • ALT N/A
  • Revenue Next Year
  • KTF N/A
  • ALT $761,880.20
  • P/E Ratio
  • KTF $23.10
  • ALT N/A
  • Revenue Growth
  • KTF N/A
  • ALT N/A
  • 52 Week Low
  • KTF $7.40
  • ALT $2.90
  • 52 Week High
  • KTF $9.12
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • KTF 63.49
  • ALT 51.79
  • Support Level
  • KTF $8.63
  • ALT $3.35
  • Resistance Level
  • KTF $8.74
  • ALT $3.66
  • Average True Range (ATR)
  • KTF 0.06
  • ALT 0.19
  • MACD
  • KTF 0.02
  • ALT 0.07
  • Stochastic Oscillator
  • KTF 96.12
  • ALT 86.18

About KTF DWS Municipal Income Trust

DWS Municipal Income Trust is a closed-ended fixed income mutual fund launched and managed by Deutsche Investment Management Americas, Inc. The company invests in the fixed income markets of the United States. The fund invests in investment-grade tax-exempt municipal securities which are exempt from federal income tax. The fund benchmarks the performance of its portfolio against the Barclays Municipal Bond Index. The Fund invests in various states, such as Texas, Florida, Pennsylvania, Illinois, and California.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: